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Summary
The arenavirus Lassa virus (LASV) causes a
severe haemorrhagic fever with high mortality in
man. The cellular receptor for LASV is dystrogly-
can (DG). DG is a ubiquitous receptor for extracel-
lular matrix (ECM) proteins, which cooperates with
b1 integrins to control cell–matrix interactions.
Here, we investigated whether LASV binding to DG
triggers signal transduction, mimicking the natural
ligands. Engagement of DG by LASV resulted in
the recruitment of the adaptor protein Grb2 and the
protein kinase MEK1 by the cytoplasmic domain of
DG without activating the MEK/ERK pathway, indi-
cating assembly of an inactive signalling complex.
LASV binding to cells however affected the activa-
tion of the MEK/ERK pathway via a6b1 integrins.
The virus-induced perturbation of a6b1 integrin
signalling critically depended on high-affinity
LASV binding to DG and DG’s cytoplasmic domain,
indicating that LASV–receptor binding perturbed
signalling cross-talk between DG and b1 integrins.
Introduction
Lassa virus (LASV) is the causative agent of a severe
haemorrhagic fever with high mortality in humans that is
endemic to West Africa and infects several hundred thou-
sand individuals per year with thousands of deaths (Gei-
sbert and Jahrling, 2004). There is neither a licensed
vaccine nor an efficacious treatment for this disease,
resulting in 15–30% mortality in hospitalized patients
(McCormick and Fisher-Hoch, 2002). Despite the wide-
spread viral replication in fatal Lassa fever cases, histo-
logical analysis revealed only modest infiltration of
inflammatory cells (Walker et al., 1982). The terminal
shock syndrome associated with fatal Lassa fever occurs
without evidence of massive cellular necrosis, vascular
damage or bleeding, suggesting that direct perturbation of
host cell function by LASV contributes to disease (McCor-
mick and Fisher-Hoch, 2002; Kunz, 2009; Moraz and
Kunz, 2011). The analysis of the virus–host cell interaction
and the consequences for host cell function are therefore
important to understand the viral pathogenesis underlying
fatal Lassa fever.
LASV belongs to the family Arenaviridae, enveloped
negative strand RNA viruses with a non-lytic life cycle
confined to the cytoplasm (Buchmeier et al., 2007). The
bisegmented genome of LASV codes for only four pro-
teins, an RNA-dependent RNA polymerase (L), the viral
nucleoprotein (NP), the matrix protein (Z) and the precur-
sor of the viral envelope glycoprotein (GPC) (Buchmeier
et al., 2007). The GPC precursor is processed by the
cellular protease subtilisin kexin isozyme-1(SKI-I)/site-1
protease (S1P) yielding the mature envelope proteins
GP1 and GP2. (Lenz et al., 2001; Beyer et al., 2003;
Rojek et al., 2008c). The GP1 part is implicated in binding
to cellular receptor(s), whereas GP2 resembles fusion-
active portions of other viral GPs (Eschli et al., 2006;
Igonet et al., 2011).
The first cellular receptor discovered for LASV and
other Old World arenaviruses is a-dystroglycan (a-DG),
the peripheral subunit of DG, a ubiquitously expressed
versatile receptor for extracellular matrix (ECM) proteins
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(Cao et al., 1998; Oldstone and Campbell, 2011). Very
recently, additional candidate receptors for LASV have
been reported: the C-type lectins DC-SIGN, LSECtin, as
well as the Tyro3/Axl/Mer (TAM) receptor tyrosine kinases
Axl and Tyro3 (Shimojima et al., 2012). While the C-type
lectins have expression patterns limited to specific cell
types, the TAM receptors Tyro3 and in particular Axl are
widely expressed, including cell types positive for DG.
Notably, in cells coexpressing DG and Axl, DG seems to
be the preferred receptor for LASV (Shimojima et al.,
2012), suggesting a role for TAM receptor kinases as
LASV receptors primarily in cells lacking functional DG.
Dystroglycan is expressed in most developing and adult
tissues, typically in cell types that adjoin basement mem-
branes (Durbeej et al., 1998) and is crucial for normal
cell–matrix adhesion (Henry and Campbell, 1998; Henry
et al., 2001). Mutations affecting DG in humans result in
severe congenital diseases (Barresi and Campbell,
2006). Encoded as a single protein, DG is proteolytically
processed into a-DG, which is extracellular, and b-DG
which is membrane anchored (Barresi and Campbell,
2006). DG provides a molecular link between the ECM
and the actin-based cytoskeleton. Alpha-DG binds with
high affinity to the ECM proteins laminin, agrin, perlecan
and neurexins and is non-covalently associated with b-DG
that interacts with the cytoskeletal adaptor proteins dys-
trophin and utrophin, which anchor the DG complex to the
actin-based cytoskeleton (Ervasti and Campbell, 1991;
1993). The cytoplasmic domain of b-DG was found to
interact with the signalling adaptor molecule Grb2 (Yang
et al., 1995), the protein kinases MEK, ERK and focal
adhesion kinase (FAK) (Yang et al., 1995; Cavaldesi
et al., 1999; Spence et al., 2004), suggesting a role of DG
in cellular signal transduction.
Several lines of evidence support a functional interac-
tion between DG and b1 integrins in the assembly of
laminin-based ECM structures (Henry et al., 2001). Lami-
nins recognize a-DG and b1 integrins via distinct LG
modules located in the C-terminal G domain of their
a-chain, LG4 and LG1–3 respectively (Hohenester et al.,
1999). Interestingly, DG and a6b1 integrins seem to have
opposing roles in the regulation of the canonical MEK/
ERK MAP kinase pathway in response to laminin (Ferletta
et al., 2003). Binding of laminin LG1–3 to a6b1 integrins
activates MEK/ERK signalling, whereas attachment of
LG4 to a-DG resulted in a dose-dependent reduction of
MEK/ERK activation (Ferletta et al., 2003). Simultaneous
binding of laminin to the two receptors likely results in a
defined equilibrium of MEK/ERK signalling critical for
normal cell–matrix adhesion.
In mammals, a-DG undergoes complex post-
translational modifications that are crucial for its function
as an ECM receptor (Barresi and Campbell, 2006; Kana-
gawa and Toda, 2006). Of particular importance are
specific O-glycan modifications of a-DG’s mucin-type
domain, which involve protein O-mannosylation and
modifications by the glycosyltransferases LARGE and
LARGE2 (Barresi et al., 2004). We and others have
shown that protein O-mannosylation and LARGE-
dependent modifications are also crucial for a-DG’s func-
tion as a high-affinity receptor for arenaviruses (Kunz
et al., 2005b) and that the viruses closely mimic the
molecular mechanisms of receptor recognition by ECM
proteins (Rojek et al., 2007a). As a consequence LASV
competes with ECM proteins for receptor binding, result-
ing in displacement of DG-bound ECM (Kunz et al.,
2005a), likely affecting DG’s function in the host cell. In
the present study, we investigated the impact of LASV
binding to a-DG on DG-mediated signal transduction. We
found that engagement of LASV affected the interaction of
DG with signalling molecules and perturbed the signalling
cross-talk with b1 integrins.
Results
Binding of inactivated LASV to cellular DG triggers
recruitment of Grb2 and MEK1 without activating MEK1
Considering the high binding affinity of LASV for a-DG
and the multivalent nature of the virus particles, we
hypothesized that virus attachment may result in
extensive receptor clustering with possible effects on
DG-mediated signal transduction. Since LASV is a BSL4
pathogen, work with live virus is restricted to laboratories
with high security containment. To circumvent this
problem, we used either inactivated virus or recombinant
retroviruses bearing the envelope glycoprotein of LASV
(Reignier et al., 2006; Rojek et al., 2006). Since receptor
binding and host cell entry of arenaviruses are mediated
exclusively by the viral GP, recombinant retroviruses dis-
playing LASV GP adopt the receptor binding characteris-
tics of LASV (Reignier et al., 2006). They represent a
suitable BSL2 surrogate for LASV and have been widely
used to study LASV–receptor interactions (Kunz et al.,
2005a,b; Reignier et al., 2006; Rojek et al., 2007a). As a
cell culture model, we chose the human lung epithelial cell
line WI-26 VA4, which had previously been utilized for
studies on DG signalling (Ferletta et al., 2003). Alpha-DG
isolated from WI-26 VA4 cells by lectin affinity purification
bound inactivated LASV with high affinity, as assessed by
virus overlay protein binding assay (Fig. 1A). In a next
step, we verified if cell attachment and entry of LASV into
WI-26 VA4 cells was indeed mediated by a-DG. For this
purpose, cells were pre-treated with increasing concen-
tration of the monoclonal antibody (mAb) IIH6 that recog-
nizes a functional glycan epitope on a-DG (Kanagawa
et al., 2004) and competes with virus binding (Kunz et al.,
2005b). Cells were then infected with LASV pseudotypes
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containing a green fluorescent protein (GFP) reporter in
their genome at a multiplicity of infection (moi) of 0.01
infectious virus particle per cell. Infected cells were
detected after 24 h by immunofluorescence (IF) detection
of the GFP reporter. Pre-treatment with mAb IIH6, but not
an IgM isotype control significantly blocked infection with
LASV pseudotypes in a dose-dependent manner, con-
firming DG as a major receptor for LASV in these cells
(Fig. 1B). The only partial inhibition of LASV pseudotype
infection in presence of 200 mg ml-1 mAb IIH6 is consis-
tent with earlier studies (Kunz et al., 2005b) and is likely
due to the high binding affinity of LASV GP to a-DG.
The cytoplasmic tail of b-DG can associate with sig-
nalling molecules, including Grb2, MEK, ERK and FAK,
suggesting a role in cellular signal transduction (Yang
et al., 1995; Cavaldesi et al., 1999; Spence et al., 2004).
We next assessed the impact of LASV binding to cellular
a-DG on the association of b-DG with these signalling
molecules. Since available anti-b-DG antibodies recog-
nize the cytoplasmic domain, interference with the
binding of signalling molecules was a concern. To cir-
cumvent this problem, we made use of a recombinant
full-length DG containing a C-terminal spacer sequence
of four amino acids (GGGS), followed by an HA-tag
(DGHA) (Fig. 2A). Previous studies demonstrated that
this C-terminal tagging of b-DG had no influence on the
biosynthesis, transport and function of DG (Rojek et al.,
2007b). Considering the biosafety restrictions of work
with live LASV and to avoid any possible effect due to
virus replication, we used inactivated LASV to study the
effect of virus binding on DG signalling. For this purpose,
LASV (strain Josiah) was grown in a BSL4 facility of the
Centers for Disease Control and inactivated by gamma
irradiation as described (Spiropoulou et al., 2002). As a
control, we used inactivated Amapari virus (AMPV), a
New World arenavirus that does not use DG as a recep-
tor (Spiropoulou et al., 2002). Previous studies had
shown that our inactivation protocol abrogated virus rep-
lication, but did not affect receptor binding (Spiropoulou
et al., 2002). In a first step, we determined binding of
LASV and AMPV to WI-26 VA4 cells. Briefly, monolayers
of WI-26 VA4 cells were cultured in microtitre plates,
chilled on ice and incubated with increasing concentra-
tions of inactivated virus. After removing unbound virus,
cells were fixed. Bound virus was detected with mAb
83.6 that recognizes a highly conserved epitope in LASV
and AMPV GP2 (Weber and Buchmeier, 1988), com-
bined with a HRP-labelled secondary antibody in a
colour reaction. Both LASV and MAPV bound WI-26 VA4
cells to a similar extent in a dose-dependent manner
(Fig. 2B). Next, WI-26 VA4 cells were transfected with
DGHA, using un-tagged DG as a control. After 48 h, cells
were incubated with inactivated LASV and AMPV (100
particles per cell) in the cold, allowing virus attachment
without receptor clustering. After removal of unbound
virus, the temperature was shifted to 37°C for 10 min.
Cells were rapidly chilled, cold detergent extracts pre-
pared and cleared lysates subjected to immunoprecipita-
tion (IP) with anti-HA matrix. Immunocomplexes were
probed for the presence of DGHA, Grb2, Sos, FAK,
MEK1/2 and ERK1/2 in Western blot. Similar amounts of
DGHA were detected in IPs from cells incubated with
LASV, AMPV and mock-treated cells (Fig. 2C), excluding
receptor downregulation and/or degradation as a conse-
quence of virus binding. In line with published data (Yang
et al., 1995; Spence et al., 2004), we detected an asso-
ciation of b-DG with Grb2 and MEK1/2, whereas neither
FAK, Sos nor ERK was detected in anti-HA immunocom-
plexes in this cell type under our experimental conditions
(Fig. 2D and E). Binding of LASV, but not AMPV resulted
in a significant increase in the amounts of b-DG-
associated Grb2 (Fig. 2D and F) and MEK1 (Fig. 2E and
F), indicating recruitment of Grb2 and MEK1 upon virus
binding. In a next step, we investigated if the observed
LASV-induced recruitment of Grb2 and MEK1 resulted in
activation of MEK1. For this purpose, we exposed cells
to LASV and AMPV, isolated HA-tagged b-DG at different
time points as described above. Immunocomplexes were
probed with a mAb specific for phosphorylated (acti-
vated) MEK1 in Western blot and signals normalized to
total MEK1. At no time point did we observe significant
phosphorylation of MEK1 (data not shown), suggesting
that the observed virus-induced recruitment of Grb2 and
MEK1 results in assembly of an inactive signalling
complex associated with b-DG.
Fig. 1. Cell entry of LASV pseudotypes in WI-26 VA4 human lung
epithelial cells is mediated by DG.
A. WI-26 VA4 cells express DG that is functional as LASV receptor.
WI-26 VA4 cells were lysed and glycoproteins enriched by affinity
purification with the lectin wheat germ agglutinin. Functional a-DG
was detected by laminin overlay assay (Ln) and virus overlay
protein binding assay using inactivated virus (LASV).
B. Blocking of infection with mAb IIH6. Monolayers of WI-26 VA4
cells were blocked with mAb IIH6 or an unrelated mouse IgM
(Control IgM) at the indicated concentrations for 2 h at 4°C. Next,
LASV pseudotypes (200 PFU) were added for 45 min. Infection
was assessed after 24 h by immunofluorescence staining for GFP.
Infected foci were counted in each well (means  SD, n = 3).
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Infection with LASV pseudotypes depends on DG, but
not b1 integrins
Several lines of evidence indicate that DG functionally
interacts with b1 integrins in the host cell (Henry et al.,
2001; Ferletta et al., 2003). While the role of DG in host
cell attachment and entry of LASV has been well estab-
lished, a possible function of b1 integrins in LASV cell
entry had not yet been addressed. To address this issue,
we exploited the fact that LASV efficiently infects wild-
type murine embryonic stem (ES) cells (Spiropoulou
et al., 2002). To define a possible role of b1 integrins in
LASV cell entry, we employed a murine ES cell line defi-
cient in b1 integrin (-/-) and the parental hemizygous
(+/-) line (Fassler and Meyer, 1995; Fassler et al.,
1995). To separate virus entry mediated by the envelope
GP of LASV from subsequent steps of virus replication,
we employed recombinant retroviruses pseudotyped
with LASVGP that contained a luciferase reporter in their
genome (Rojek et al., 2007a). As a control, we used ret-
roviral pseudotypes containing the GP of AMPV, which is
independent of DG. Murine ES cell with the genotypes
DG (+/-), DG (-/-), b1 integrin (+/-) and b1 integrin (-/-)
were infected with retroviral pseudotypes bearing the
GPs of LASV and AMPV. Since murine retroviruses
show relatively low levels of reporter gene expression in
murine ES cells (Reignier et al., 2006), pseudotype
infection was performed at high moi (10). Infection was
assessed after 48 h by luciferase assay. In line with pre-
vious reports, cells deficient in DG showed markedly
reduced susceptibility to LASV pseudotypes, whereas
AMPV pseudotype infection was not affected (Fig. 3). In
contrast, cells deficient in b1 integrins showed similar
susceptibility to both pseudotypes (Fig. 3) indicating that
b1 integrins are dispensable for LASVGP-mediated cell
attachment and entry.
Attachment of inactivated LASV and LASV pseudotypes
to cells perturbs activation of MEK/ERK signalling
by laminin
Previous studies demonstrated that cell adhesion to
laminin results in activation of the MEK/ERK pathway via
b1 integrins, which is counterbalanced by DG (Ferletta
et al., 2003). To validate our experimental system, we
monitored the activation of the MEK/ERK pathway in
WI-26 VA4 cells in response to cell adhesion to laminin
employing a cell adhesion assay described previously
(Ferletta et al., 2003). Briefly, WI-26 VA4 cells were cul-
tured for 16 h under serum starvation, detached and
single-cell suspension prepared. Cells were then added
to culture dishes coated with purified mouse laminin-1 or
left in suspension. At different time points, cells were
lysed, total protein extracted and the phosphorylation of
MEK and ERK detected by specific antibodies to the
phosphorylated forms of the kinases in Western blot. For
normalization, total MEK/ERK was detected with anti-
bodies that are insensitive to the phosphorylation state.
Adhesion of WI-26 VA4 cells to laminin-1 resulted in the
induction of phosphorylation of MEK and ERK with
maximal activation after 40–60 min, a kinetic profile con-
sistent with published work (Ferletta et al., 2003)
(Fig. 4A). Addition of the specific MEK inhibitor PD98059
abrogated phosphorylation of ERK, confirming that the
enhanced phosphorylation of ERK was mediated by
MEK (Fig. 4B).
Next, we addressed the impact of LASV binding to
cellular a-DG on laminin-induced signalling. For this
purpose, single-cell suspensions of WI-26 VA4 cells were
mixed with inactivated LASV or AMPV (10 particles per
cell) immediately before adding to plates coated with
laminin-1. The presence of the viruses did not affect the
number of adherent cells (data not shown), excluding
simple blocking of cell adhesion by the virus. After 40 min,
cells were lysed and the phosphorylation of MEK and
ERK detected. As shown in Fig. 4C, cell adhesion to
laminin-1 in presence of LASV, but not AMPV resulted in
significantly reduced activation of MEK and ERK phos-
phorylation (Fig. 4C and D).
The MEK/ERK kinase pathway is influenced by many
cellular signalling cascades including cellular responses
to stress. To exclude artefacts due to unknown contami-
nations that may be present in our inactivated virus prepa-
rations, we performed analogous experiments with
retroviral pseudotypes for LASV and AMPV. As shown in
Fig. 4E and F, adhesion of WI-26 VA4 cells to laminin in
Fig. 3. Infection of LASV pseudotypes is independent on b1
integrins. DG (-/-) and DG (+/-), b1 integrin (-/-) and b1 integrin
(+/-) mouse ES cells cultured in 96-well plates were infected with
the retroviral pseudotypes bearing the GPs of LASV or AMPV
(moi = 10). Infection was assessed after 48 h by luciferase assay
(n = 3, SD).
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presence of pseudotypes gave similar results than
obtained with inactivated viruses. Only the presence of
pseudotypes bearing the GP of LASV, but not AMPV
significantly reduced the induction of MEK/ERK phospho-
rylation in response to cell adhesion to laminin. Together,
the data suggest that LASV attachment to cells somehow
perturbs laminin-induced activation of the MEK/ERK
pathway.
Activity of the MEK/ERK pathway is dispensable for cell
entry of LASV pseudotypes
The ability of LASV to modulate cellular MEK/ERK signal-
ling raised the possibility that this pathway may be
involved in cell entry of the virus. To test this possibility,
we pre-treated cells with the MEK inhibitor PD98059
at concentrations that abrogated ERK phosphorylation
(Fig. 4B), followed by infection with LASV and AMPV
pseudotypes. When assessed after 48 h, pre-treatment
with the MEK inhibitor did not significantly affect LASV
pseudotype infection, indicating that MEK/ERK signalling
is dispensable for LASVGP-mediated cell attachment and
entry (Fig. 5A). Since these first experiments detected
infection at 48 h post infection, i.e. at a late time point, we
next examined the cell entry kinetics of LASV in presence
of the MEK inhibitor PD98059. Upon receptor binding,
LASV is taken up by clathrin- and caveolin-independent
endocytosis and rapidly delivered to late endosomes,
where low pH-dependent membrane fusion occurs
(Borrow and Oldstone, 1994; Quirin et al., 2008; Rojek
et al., 2008a,b). To assess how fast receptor-bound LASV
pseudotypes trafficked to late endosomes, we determined
the time required for the virus to become resistant to the
lysosomotropic agent ammonium chloride. When added
to cells, ammonium chloride raises the endosomal pH
rapidly and blocks low pH-dependent membrane fusion
without causing overall cytotoxicity (Ohkuma and Poole,
1978; 1981). WI-26 VA4 cells were either pre-treated with
Fig. 4. Binding of inactivated LASV to cells perturbs laminin-induced activation of the ERK-MAP kinase pathway.
A. Phosphorylation of MEK and ERK in WI-26 VA4 cells in response to cell adhesion to laminin-1. Serum-starved cells were detached and
seeded onto wells coated with laminin-1 or kept in suspension. At the indicated time points, total-cell lysates were prepared and subsequently
analysed for the presence of MEK1/2 and ERK1/2 as well as the phosphorylated forms of the kinases using specific antibodies.
B. ERK is phosphorylated via MEK: suspensions of serum-starved cells were incubated with the MEK-specific inhibitor PD98059 (50 mM) or
solvent control for 30 min and then plated onto wells coated with laminin-1 for 40 min. The phosphorylated forms of MEK1/2 and ERK1/2,
MEK2 and ERK2 were detected in total-cell lysates.
C. Binding of inactivated LASV to cells reduces laminin-induced activation of MEK and ERK: serum-starved WI-26 VA4 cells were detached,
mixed with inactivated LASV or AMPV (10 particles per cell), or no virus, and plated onto wells coated with laminin-1. After 40 min of cell
adhesion, total-cell lysates were prepared and analysed for the presence of phosphorylated MEK and ERK as in (A).
D. Quantification of (C): the signal for phosphorylated MEK1/2 and ERK1/2 in the control samples set as 100% (n = 3, SD).
E and F. Binding of LASV pseudotypes reduces laminin-induced activation of MEK and ERK: experiment was performed as in (C) and (D)
using retroviral pseudotypes of LASV and AMPV (10 PFU per cell) and pseudotypes without GP (no GP).
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PD980592 for 1 h or mock treated with vehicle (DMSO)
only. Cells were then incubated with LASV pseudotypes in
the cold, to allow virus attachment without internalization.
Unbound virus was removed and cells quickly shifted to
37°C to allow virus internalization in presence or absence
of PD980592. After different time points, 20 mM ammo-
nium chloride was added to cells and kept throughout the
experiment. After 24 h, cells were fixed and infection
assessed by detection of the luciferase reporter activity.
As shown in Fig. 5B, pre-treatment of cells with PD98059
had no significant effects on the cell entry kinetics of
LASV pseudotypes, suggesting that activity of the MEK/
ERK pathway is dispensable for virus cell entry.
Binding of LASV pseudotypes to cells perturbs
activation of MEK and ERK via the integrin a6b1
The major laminin-binding integrins in WI-26 VA4 cells
are the integrins a6b1 and a3b1, whereas a6b4 integrin
is present only at low levels (Ferletta et al., 2003). Since
mouse laminin-1 binds only to human a6b1 but not
a3b1 integrins (Delwel et al., 1994), laminin-1-induced
activation of MEK and ERK in WI-26 VA4 cells is thought
to be mediated by a6b1 integrins (Ferletta et al., 2003).
To validate the role of a6b1 integrins in laminin-1-
induced MEK/ERK signalling in our system, serum-
starved WI-26 VA4 cells were added to tissue culture
plates coated with the signalling inducing anti-integrin a6
mAb GoH3, as well as mAb P1B5 anti-a3. Consistent
with published reports, only adhesion to the mAb anti-
integrin a6, but not anti-integrin a3 resulted in significant
activation of MEK and ERK (Fig. 6A), confirming the
role of a6b1 integrins in laminin-mediated MEK/ERK
activation.
To specifically address the effect of LASV binding to
cells on the activation of MEK/ERK via a6b1 integrin-
mediated signalling, we performed cell adhesion to mAb
anti-a6 in presence of LASV and MAPV pseudotypes.
Fig. 5. MEK1 activity is dispensable for cell entry of LASV
pseudotypes.
A. Infection of LASV pseudotypes is not affected by the MEK
inhibitor PD98059. Monolayers of WI-26 VA4 cells were pre-treated
with PD98059 (50 mM) or solvent control (DMSO) for 30 min,
followed by infection with LASV and AMPV pseudotypes
(moi = 0.1). Infection was detected by luciferase assay and fold
increase of luminescence above background is given
(means  SD, n = 3).
B. The MEK inhibitor PD98059 does not affect LASV cell entry
kinetics. Monolayers of WI-26 VA4 cells were pre-treated with
PD98059 as in (A), followed by incubation with LASV pseudotypes
(moi = 0.1) in the cold in presence of the drug. After 1 h, unbound
virus was removed and pre-warmed (37°C) medium containing the
drug added. At the indicated time points, 20 mM ammonium
chloride was added and left throughout the experiment. At 24 h
post infection was detected by luciferase assay as in (A)
(means  SD, n = 3). Please note that the apparent differences in
infection at 60 min were not statistically significant.
Fig. 6. Binding of LASV pseudotypes to cells blocks a6b1 integrin-mediated activation of MEK and ERK.
A. Induction of MEK and ERK phosphorylation by anti-a6 integrin antibody. Serum-starved WI-26 VA4 cells were detached and plated onto
wells coated with antibodies to a6 and a3 integrin or an isotype control antibody for 40 min. Activation of MEK and ERK was determined by
Western blot.
B. Binding of LASV pseudotypes reduces MEK and ERK phosphorylation induced by anti-a6 integrin antibody: serum-starved WI-26 VA4 cell
suspensions were mixed with pseudotypes of LASV and AMPV at 10 particles per cell or control pseudotypes containing no GP (no GP) and
plated onto wells coated with antibodies to a6. After 40 min of cell adhesion total-cell lysate were prepared and phosphorylation of MEK and
ERK analysed by Western blot.
C. Quantification of (B), setting the signal for phosphorylated MEK1/2 and ERK1/2 in the control sample (no GP) as 100% (n = 3, SD).
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Single-cell suspensions of serum-starved WI-26 VA4 cells
were mixed with LASV and MAPV pseudotypes at 10
particles per cell and immediately added to cell culture
plates coated with mAb GoH3 anti-a6 integrin At 40 min,
cells were lysed and phosphorylation of MEK and ERK
detected by Western blot. Pseudotypes of LASV, but not
AMPV specifically perturbed the activation of MEK and
ERK induced by mAb anti-a6 (Fig. 6B and C), suggesting
that LASVGP binding to cells perturbs activation of MEK
and ERK via the integrin a6b1.
LASV pseudotype-induced perturbation of a6b1
integrin-mediated signalling depends on functional DG
To address the involvement of DG in the LASV-induced
perturbation of a6b1 integrin signalling, we utilized two
well-characterized DG mutants (Fig. 7A). DGE contains
the LASV binding site but lacks the N-terminal domain
and does not undergo the post-translational modifications
required for LASV binding (Kanagawa et al., 2004).
DGDCyt lacks the cytoplasmic tail of b-DG, but shows
normal cell surface expression and virus binding (Kunz
et al., 2003). First, we verified virus-binding phenotypes of
DGE and DGDCyt. For this purpose, the DG mutants and
wild-type DG were expressed in DG (-/-) ES cells using
adenoviral (AdV) vectors (Kunz et al., 2001). After 48 h,
total-cell lysates were prepared and glycoproteins iso-
lated by wheat germ agglutinin (WGA) affinity purification
(Michele et al., 2002). Glycoprotein fractions were sepa-
rated by SDS-PAGE and virus overlay assay performed
with inactivated LASV (Cao et al., 1998). As expected, the
a-DG part of DGE lacked detectable virus binding,
Fig. 7. Functional a-DG and the cytoplasmic domain of b-DG are involved in LASV pseudotype-induced inhibition of a6 integrin-mediated
MEK/ERK activation.
A. Schematic representation of the DG mutants.
B. Detection of the a-DG parts of the DG variants. DGE, DGDCyt, wild-type DG and GFP were expressed in DG (-/-) ES cells using AdV
vectors. After 48 h, total membrane extracts were prepared and probed with an antibody to HA and in virus overlay protein binding assay
(VOPBA).
C. Overexpression of DG DN mutants releases LASV pseudotype-induced inhibition of a6 integrin mediated MEK/ERK activation. WI-26 VA4
cells were infected with AdV expressing the DG variants. After 48 h, cells were serum-starved and detached. Single-cell suspensions were
mixed with LASV and AMPV pseudotypes and plated onto wells coated with antibody to a6. Activation of ERK was determined by Western
blot.
D. Quantification of (B), setting the signal for phosphorylated MEK1/2 and ERK1/2 in the control sample (no GP) as 100% (n = 3, SD).
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whereas a-DG from DGDCyt and wild-type DG bound
LASV with high affinity (Fig. 7B).
To test the effect of the DG mutants on LASV-induced
modulation of a6b1 integrin signalling, WI-26 VA4 cells
were infected with AdV vectors expressing DGE, DGDCyt
and wild-type DG. After 48 h, cells were serum-starved for
16 h, detached, and added to plates pre-coated with mAb
anti-a6 integrin in presence of LASV and AMPV pseudot-
ypes. Cells were lysed and phosphorylation of ERK
assessed by Western blot. In cells overexpressing DGE
and DGDCyt the inhibition of anti-a6 integrin-induced ERK
phosphorylation by LASV pseudotypes was significantly
released (Fig. 7C and D). As expected, no effect was
observed in cells exposed to AMPV pseudotypes (Fig. 7C
and D). The ability of the DG mutants to partially release
the LASV-induced blocking of a6b1 integrin-mediated
MEK/ERK activation suggest that LASV-pseudotype
induced perturbation of a6b1 integrin-mediated signalling
involves functional DG.
Discussion
Viruses have evolved to use a plethora of different cell
surface molecules with very different biochemical charac-
teristics and functions for host cell attachment and entry
(Smith and Helenius, 2004; Marsh and Helenius, 2006). In
some cases, the pathogens evolved to mimic the nature
of the natural ligands of their cellular receptors, like, e.g.
the integrin binding sites found in some picornaviruses
(Baranowski et al., 2003). Old World arenaviruses, includ-
ing LASV provide a striking example for this phenomenon
(Rojek et al., 2007a; Oldstone and Campbell, 2011).
Similar to DG’s ECM ligands, high-affinity binding of
arenaviruses critically depends on functional glycans
present on a-DG. A comparative study between ECM
proteins and arenaviruses revealed that the viruses mimic
the molecular mechanism of receptor binding of a-DG’s
ECM ligands in a striking manner as both recognizing
a highly conserved glycan epitope derived from the
glycosyltransferase LARGE (Rojek et al., 2007a). In the
present study we investigated the consequences of this
‘mimicry’ on the normal function of DG in the host cell, in
particular DG-mediated signal transduction.
Several lines of evidence indicate that in the host cell,
DG can associate with signalling molecules, including
components of the MEK/ERK signalling pathway, Grb2,
MEK and ERK (Yang et al., 1995; Spence et al., 2004;
Moore and Winder, 2010). However the roles of these
interactions for the cellular function of DG are currently
unclear. Engagement of cellular a-DG by LASVGP, dis-
played on either inactivated LASV virions or retroviral
pseudotypes, resulted in significant recruitment of Grb2
and MEK1 by the DG complex. Interestingly, we were
unable to detect recruitment of the GTP exchange factor
Sos, required by Grb2 for the activation of the canonical
Ras/Raf/MEK/ERK pathway and found no evidence for
activation of MEK/ERK signalling upon virus binding at
any point, suggesting recruitment of Grb2 and MEK1 into
an inactive signalling complex. An important role for such
an inactive signalling complex for viral entry seemed
rather unlikely. We therefore investigated the effect of
these virus-induced changes on DG’s association with
Grb2 and MEK1 on the known cross-talk between DG and
b1 integrins.
Previous work by us and others showed that attach-
ment and cell entry of LASV critically depends on the
high-affinity interaction between LASVGP and cellular
a-DG (Cao et al., 1998; Kunz et al., 2005a; Reignier et al.,
2006). Our present study revealed that b1 integrins are
dispensable for attachment and cell entry of LASV
pseudotypes. However, binding of inactivated LASV and
LASV pseudotypes to cells markedly reduced the phos-
phorylation of MEK and ERK in response to laminin-1 and
signalling activating antibodies to a6b1 integrins. Using
mutants of DG, which either were deficient in virus binding
or lacked the cytoplasmic tail of b-DG, we found that the
effect of LASV cell attachment on a6b1 integrin signalling
involves functional DG. Together, our data provide evi-
dence that high-affinity LASV binding to cellular a-DG
perturbs the signalling cross-talk between DG and
a6b1 integrins, shifting the normal signalling equilibrium
towards inhibition of the MEK/ERK pathway.
It is currently unclear how LASV binding to a-DG modu-
lates MEK/ERK signalling through a6b1 integrins. To acti-
vate ERK, integrins can use two distinct pathways, one,
involving FAK, and the other, the adaptor protein Shc
(Giancotti and Ruoslahti, 1999). In both pathways,
tyrosine phosphorylation of the adaptor proteins gener-
ates binding sites for the SH2 domain of Grb2, which in
turn recruits Sos leading to activation of the Ras/Raf/MEK/
ERK cascade. In contrast, binding of Grb2 to b-DG occurs
in an SH3-dependent manner (Yang et al., 1995). Here we
show that virus binding affects the association of DG with
Grb2. However, an association of DG with Grb2 and MEK1
is already detected in uninfected cells and the extent of
recruitment upon virus binding seems modest (Fig. 2F). It
seems therefore rather unlikely that virus–receptor binding
can sufficiently sequester signalling molecules like Grb2
and MEK1 to affect a6b1 integrin signalling. One might
speculate that LASV binding to DG induces a negative
regulatory signal of unknown nature that may affect a6b1
integrin-induced MEK/ERK signalling (Fig. 8).
Intrigued by the observation that binding of LASV to
cells can modulate cellular MEK/ERK signalling, we
investigated the role of this pathway for LASV cell entry.
Inhibition of MEK, which is the only kinase that can phos-
phorylate ERK, did not affect infection of cells with LASV
pseudotypes, making a role of this pathway in LASVGP-
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mediated cell entry rather unlikely. Due to biosafety
restrictions associated with work with live LASV, a pos-
sible role of MEK/ERK signalling in post-entry steps of
LASV replication have not yet been addressed, but will be
pursued in future studies.
Since DG and a6b1 integrins are coexpressed on
a wide variety of human cell types involved in LASV
pathogenesis like epithelial cells, endothelial cells and
macrophages (Wei et al., 1998; ffrench-Constant and
Colognato, 2004) the impact of LASV binding on
DG-mediated signalling may affect normal cell function in
LASV infected individuals. A possible concern with our in
vitro studies is the relatively high particle/cell ratios used.
However, in late stages of fatal human Lassa fever, virus
loads often exceed 109 infectious particles per ml of
blood and similar virus loads are found in many tissues
(Walker et al., 1982; McCormick and Fisher-Hoch, 2002;
Moraz and Kunz, 2011). In this situation, extensive
binding of virus particles to cellular a-DG may result in
significant perturbation of DG-mediated signalling that
may contribute to cellular dysfunctions that are associ-
ated with the Lassa shock syndrome.
In fatal Lassa fever there is surprisingly little inflamma-
tion and tissue destruction, vascular damage is mild and
disseminated intravascular coagulation (DIC) is rare
(Walker et al., 1982; McCormick and Fisher-Hoch, 2002).
The absence of classical hallmarks of immunopathology
in fatal disease suggests that the direct interaction of the
virus with host cells may contribute to some aspects
of pathogenesis, such as vascular leakage and oedema
formation. Among other mechanisms, the virus-induced
perturbation of ECM-induced cell signalling shown in this
study, may contribute to the functional alterations of epi-
thelial and vascular endothelial cells that precede shock
and death (Fisher-Hoch et al., 1987). This type of LASV-
induced receptor signalling reported here is likely due to
the extensive mimicry of endogenous ligand binding by
the pathogen. The consequent perturbation of cell signal-
ling appears as a ‘collateral damage’ inflicted on the cell
that may contribute to viral pathogenesis.
Fig. 8. Working model: binding of LASV to DG perturbs signalling cross-talk with b1 integrins.
A. Binding of laminin to cellular DG modulates MEK/ERK signalling through a6b1 integrins: laminin engages cellular DG via the LG domains 4
and 5 of the a1 chain (Hohenester et al., 1999) and binding critically depends on a-DG-linked O-glycans, in particular sugar polymers
attached by LARGE (Kanagawa et al., 2004). Binding of laminin to a6b1 integrins involves the LG domains 1–3 of a1 (Hohenester et al.,
1999) and results in activation of MEK/ERK signalling (Ferletta et al., 2003). Simultaneous binding of laminin to DG via LG4/5 inhibits
activation of MEK/ERK via a6b1 integrins (Ferletta et al., 2003).
B. High-affinity binding of LASV to cellular a-DG perturbs the signalling cross-talk between DG and a6b1 integrins (this study): binding of
inactivated LASV and LASV pseudotypes to cellular DG inhibits activation of a6b1 integrins via laminin or a signalling-inducing antibody to a6.
The effect of LASV on a6b1 integrin signalling depends on the functional O-glycosylation of a-DG and the cytoplasmic domain of b-DG. The
nature of the inhibitory signal induced by binding of laminin LG4/5 and LASV is currently unknown.
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Experimental procedures
Proteins and antibodies
Mouse laminin-1 was from Gibco-BRL (Gaithersburg, MD).
Monoclonal antibody (mAb) IIH6 anti-a-DG has been described
(Ervasti and Campbell, 1991). Polyclonal rabbit anti-laminin-1
was from Sigma (St. Louis, MO) and rabbit anti-influenza HA
(Y11) and mouse anti-HA (F7) from St. Cruz Biotechnology (St.
Cruz, CA). HRP-conjugated secondary Abs and Streptavidin-
HRP were from Pierce. MAbs to human integrins P1B5 anti-a3
and GoH3 anti-a6 were from Chemicon (Temecula, CA) and BD
Biosciences (San Jose, CA) respectively. Mouse mAbs specific
for MEK1, MEK2, ERK1 and ERK2 were from Transduction
Laboratories (Lexington, KY), rabbit polyclonal Abs against
phospho-MEK1/2 (S217/221) and phospho-ERK1/2 (T202/Y204)
were from New England Biolabs (Beverly, MA). Polyclonal rabbit
anti-Sos-1 Abs were from Upstate (Lake Placid, NY), mouse mAb
anti-Grb2 from Chemicon, and rabbit polyclonal Ab to p125FAK
from St. Cruz. The Steady Glo® and Bright-Glo® luciferase
assay systems were obtained from Promega (Madison, WI). The
MEK-specific inhibitor PD98059 was obtained from Calbiochem.
Cell lines
WI-26 VA4 cells (ATCC CCL-95.1) were cultured in DMEM,
10% (v/v) FBS, supplemented with glutamine, and penicillin/
streptomycin. Embryonic stem (ES) cells DG (+/-), DG (-/-) have
been described (Henry and Campbell, 1998). Mouse ES cells b1
integrin (+/-) and b1 integrin (-/-) (Fassler and Meyer, 1995;
Fassler et al., 1995) were kindly provided by Dr R. Fassler. All ES
cell lines were cultured as described (Henry and Campbell,
1998).
Virus strains, purification and quantification
Recombinant AdV DGDH30-A316 (DGE) and DGDCyt and wt DG
have been described (Kunz et al., 2001; 2003). Lassa virus
(LASV) strain Josiah and Amapari (AMPV) virus were obtained
from the collection at the Special Pathogens Branch, Center for
Disease Control and Prevention in Atlanta GA and inactivated
viruses produced as reported (Spiropoulou et al., 2002). Retro-
viral pseudotypes expressing GFP and luciferase reporters were
produced as described (Rojek et al., 2006) and, where indicated,
inactivated by UV irradiation for 5 min. Inactivation was verified
by luciferase assay.
Immunoblotting and VOPBA
Proteins were separated by gel electrophoresis and transferred
to nitrocellulose. After blocking in 5% (w/v) skim milk in PBS,
membranes were incubated with Abs used at following concen-
trations: mAb IIH6, mAb F7, mAb 8D5 and polyclonal Abs FTP,
AP83 and Y11 (10 mg ml-1) in 2% (w/v) skim milk, PBS for 12 h at
6°C. Abs to MEK1/2, ERK1/2, Sos-1, Grb-2, p125FAK, phospho-
MEK1/2 and phospho-ERK1 at 1:1000 in 2% (w/v) skim milk,
TBS for 12 h at 6°C. Secondary Abs coupled to HRP were
applied 1:5000 in PBS, 0.1% (w/v) Tween for 1 h at room tem-
perature. Blots were developed by enhanced chemilumines-
cence (ECL) using Super Signal West Pico ECL Substrate
(Pierce). Laminin overlay assay (LOA) and VOPBA with
g-inactivated LASV, and AMPV were performed as described
(Kunz et al., 2005b).
Virus cell binding assay
Monolayers of WI-26 VA4 cells were cultured in 96-well microti-
tre plates. For virus binding, medium was removed, cells
washed twice with PBS, chilled on ice and blocked for 1 h in 1%
(w/v) FBS/PBS containing 0.1% (w/v) of sodium azide. Cells
were incubated with the indicated concentrations of inactivated
LASV and AMPV in 1% (w/v) FBS/PBS/0.1% (w/v) sodium
azide. After 1 h on ice, cells were washed three times with cold
PBS and fixed with 4% (w/v) paraformaldehyde supplemented
with 0.1% (w/v) glutaraldehyde for 20 min in ice. For detection of
bound virus, cells were incubated with mAb 83.6 (20 mg ml-1
purified IgG) overnight in the cold. After three washes in PBS,
primary antibody was detected with goat anti-mouse IgG conju-
gated to HRP for 45 min in the cold. After three wash-steps in
PBS, HRP-conjugated secondary antibody was detected in a
colour reaction using ABTS [2,2′azino-bis(3-ethylbenzthiazoline-
6-sulfonic acid)] substrate and OD405 detected in an ELISA
reader.
Infection of cells with retroviral pseudotypes
Cells were plated in 96-well plates in a density of 104 cells per
well. After 24 h, retroviral pseudotypes were added at the indi-
cated moi and incubated for 1 h at 37°C. The viral particles were
removed, cells washed twice with DMEM and fresh medium
added. Luciferase activity was determined by Steady-Glo®
luciferase assay except in murine ES cells. AdV-mediated gene
transfer of wild-type DG and the DG DN mutants DGE (DH30-
A316) and DGDCyt was performed as described (Kunz et al.,
2005b). After 48 h, the indicated infectious units (iu) of pseudot-
ypes were added to AdV transfected DG (-/-) ES cells, as well as
untreated control cells and incubated for 1 h at 37°C. The viral
particles were removed, cells washed twice with DMEM and fresh
medium added. Infection was quantified by Bright Glo® luciferase
assay. Luminescence was calculated as fold increase over back-
ground signals obtained from uninfected cells. Cell entry kinetics
of LASV pseudotypes were performed as described (Rojek et al.,
2008b). Blocking of infection with mAb IIH6 was done as reported
(Kunz et al., 2005b).
Co-immunoprecipitation
For virus binding and co-IP of b-DG with signalling molecules,
WI-26 VA4 cells were transfected with DGHA and DGwt with
Superfect® (QIAGen). After 48 h, cells were exposed to purified,
inactivated LASV, AMPV, or LASV- and AMPV pseudotypes at
a particle to cell ratio of 1:100 for the indicated time periods. To
detect changes in the association of signalling molecules with
b-DG, co-IP was performed as described (Rojek et al., 2007b)
using either mAb F7 or Y11 immobilized on Sepharose 4B for
IP of DHHA and the abovementioned Abs for detection of sig-
nalling molecules in Western blot. IP with mouse mAb F7 were
analysed with polyclonal rabbit Abs and IP with pAb Y11 with
mouse mAbs.
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Detection of MEK/ERK activation by cell adhesion to
laminin and anti-a6 integrin Abs
Cell adhesion assays were performed according to Ferletta et al.,
2003. MEK/ERK activation was detected from WI-26 VA4 cells that
had been seeded to confluence, serum starved for 16–24 h,
detached and plated on laminin-1 or wells pre-coated with mAbs to
a3 and a6 integrins in presence or absence of purified inactivated
LASV, AMPV, or LASV- and AMPV pseudotypes at a particle to
cell ratio of 1:10 for the indicated time periods. Phosphorylated and
total MEK and ERK were determined by Western blot as described
above and the degree of phosphorylation determined as
described (Ferletta et al., 2003) using densitometry (Kunz et al.,
2004). For overexpression of the DN DG mutants DGE and
DGDCyt and wt DG in WI-26 VA4 cells we used AdV vectors
(moi = 100) for gene transfer as described (Kunz et al., 2005b).
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